Next report date
Report period
Q1 2024
EPS estimate
0.28USD
Revenue estimate
237.25 MUSD
1.21USD
93.12 MUSD
944.61 MUSD
34.12 M
About HISAMITSU PHARMACEUTICAL CO INC
Sector
Headquarters
Tosu
Founded
1847
Website
ISIN
JP3784600003
FIGI
BBG000D0R601
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HTSUF is 24.56 USD — it has decreased by 2.62% in the past 24 hours. Watch Hisamitsu Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hisamitsu Pharmaceutical Co., Ltd. stocks are traded under the ticker HTSUF.
Hisamitsu Pharmaceutical Co., Ltd. is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
HTSUF stock is 6.41% volatile and has beta coefficient of 0.37. Track Hisamitsu Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Hisamitsu Pharmaceutical Co., Ltd. there?
HTSUF earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.17 USD resulting in a −7.84% surprise. The estimated earnings for the next quarter are 0.14 USD per share. See more details about Hisamitsu Pharmaceutical Co., Ltd. earnings.
Hisamitsu Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 230.32 M USD despite the estimated figure of 222.46 M USD. In the next quarter revenue is expected to reach 460.00 M USD.
Yes, you can track Hisamitsu Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
HTSUF stock has fallen by 2.62% compared to the previous week, the month change is a 7.39% fall, over the last year Hisamitsu Pharmaceutical Co., Ltd. has showed a 14.67% decrease.
HTSUF net income for the last quarter is 12.40 M USD, while the quarter before that showed 24.90 M USD of net income which accounts for −50.21% change. Track more Hisamitsu Pharmaceutical Co., Ltd. financial stats to get the full picture.
Today Hisamitsu Pharmaceutical Co., Ltd. has the market capitalization of 1.84 B, it has decreased by 0.79% over the last week.
Hisamitsu Pharmaceutical Co., Ltd. dividend yield was 2.19% in 2023, and payout ratio reached 46.80%. The year before the numbers were 2.21% and 57.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, HTSUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hisamitsu Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
HTSUF reached its all-time high on Oct 16, 2013 with the price of 556.00 USD, and its all-time low was 23.36 USD and was reached on Oct 12, 2022. View more price dynamics on HTSUF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hisamitsu Pharmaceutical Co., Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hisamitsu Pharmaceutical Co., Ltd. stock shows the sell signal. See more of Hisamitsu Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Hisamitsu Pharmaceutical Co., Ltd. future price: according to them, HTSUF price has a max estimate of 25.54 USD and a min estimate of 25.54 USD. Watch HTSUF chart and read a more detailed Hisamitsu Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Hisamitsu Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hisamitsu Pharmaceutical Co., Ltd. EBITDA is 121.73 M USD, and current EBITDA margin is 12.94%. See more stats in Hisamitsu Pharmaceutical Co., Ltd. financial statements.